MOESM2 of Acceptability of study procedures (self-collected introital swabs, blood draws and stool sample collection) by students 10–16 years for an HPV vaccine effectiveness study: a pilot study

Additional file 2. The pilot survey questionnaire: it includes the demographic characteristics of the girls who participated in the study as well as questions that assessed their willingness to participate in the study by providing blood, stool and self collected introital vaginal swab

Parents'/Guardians' Views Regarding Cervical Cancer and Probable Vaccination of Boys with HPV Vaccines.

<p>Significance set at: *p≤0.05; **p≤0.01, ***p≤0.001; <b>#</b>Total scores for parents willing to allow sons to be given the HPV vaccine was greater than 681 and those not willing greater than 85 because multiple responses were allowed.</p><p>Parents'/Guardians' Views Regarding Cervical Cancer and Probable Vaccination of Boys with HPV Vaccines.</p

Parents/Guardians' Beliefs about the Likelihood of Future Vaccination of Boys with the HPV Vaccine.

<p>Significance set at: *p≤0.05; **p≤0.01, ***p≤0.001; Deficits in the sample for each group represents cases of non-response to different statements.</p><p>Parents/Guardians' Beliefs about the Likelihood of Future Vaccination of Boys with the HPV Vaccine.</p

Parents' Characteristics by Willingness to Accept Boys' HPV Vaccination.

<p>Significance set at: *p≤0.05; **p≤0.01, ***p≤0.001; Deficits in the sample for each group represents cases of non-response to different statements.</p><p>Parents' Characteristics by Willingness to Accept Boys' HPV Vaccination.</p

Beliefs and Attitudes about Cervical Cancer, HPV, HPV Vaccine and HPV Vaccination of Boys.

<p>Significance set at: *p≤0.05; **p≤0.01, ***p≤0.001; Deficits in the sample for each group represents cases of non-response to different statements.</p><p>Beliefs and Attitudes about Cervical Cancer, HPV, HPV Vaccine and HPV Vaccination of Boys.</p

Knowledge about HPV and HPV Vaccine by Parental Willingness to Allow Son(s) to be given Probable HPV Vaccine in future.

<p>Significance set at: *p≤0.05; **p≤0.01, ***p≤0.001; Deficits in the sample for each group represents cases of non-response to different statements.</p><p>Knowledge about HPV and HPV Vaccine by Parental Willingness to Allow Son(s) to be given Probable HPV Vaccine in future.</p

Univariable analysis for factors associated with persistent hypertension at three months after delivery.

<p>Univariable analysis for factors associated with persistent hypertension at three months after delivery.</p

Comparison of characteristics of women with and without persistent hypertension at 3 months after delivery.

<p>Comparison of characteristics of women with and without persistent hypertension at 3 months after delivery.</p

Predictors of persistent hypertension at three months after delivery.

<p>Predictors of persistent hypertension at three months after delivery.</p

Additional file 1: Checklist S1. of Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial

CONSORT checklist for cluster randomised trials. (DOCX 27 kb